logo image
  • News
    • People Moves
    • Deal Wins
    • Demand Drivers
    • M&A and Funding
    • Financial Results
    • Technology
    • Academia
    • Industry News
    • Features
    • Machine Translation
    • — Divider —
    • Slator Pro
    • — Divider —
    • Press Releases
    • Sponsored Content
  • Data & Research
    • Research Reports & Pro Guides
    • Language Industry Investor Map
    • Real-Time Charts of Listed LSPs
    • Language Service Provider Index
  • Podcasts & Videos
  • Events
    • Design Thinking – February 2021
    • — Divider —
    • SlatorCon Coverage
    • Other Events
  • Directory
  • RFP Center
  • Jobs
MENU
  • News
    • People Moves
    • Deal Wins
    • Demand Drivers
    • M&A and Funding
    • Financial Results
    • Technology
    • Academia
    • Industry News
    • Features
    • Machine Translation
    • — Divider —
    • Slator Pro
    • — Divider —
    • Press Releases
    • Sponsored Content
  • Data & Research
    • Research Reports & Pro Guides
    • Language Industry Investor Map
    • Real-Time Charts of Listed LSPs
    • Language Service Provider Index
  • Podcasts & Videos
  • Events
    • Design Thinking – February 2021
    • — Divider —
    • SlatorCon Coverage
    • Other Events
  • Directory
  • RFP Center
  • Jobs

Advertise on Slator! Download the 2021 Online Media Kit Now

  • Slator Market Intelligence
  • Slator Advertising Services
  • Slator Advisory
  • Login
Search
Generic filters
Exact matches only
Advertisement
So What Are Clinical Research Organizations and Why Should LSPs Care?

5 years ago

October 2, 2015

So What Are Clinical Research Organizations and Why Should LSPs Care?

Demand Drivers ·

by Gino Diño

On October 2, 2015

5 years ago
Demand Drivers ·

by Gino Diño

On October 2, 2015

So What Are Clinical Research Organizations and Why Should LSPs Care?

Contract research organizations (CROs) specialize in various stages of clinical trials and research for life sciences from bio-pharmaceuticals to medical technologies. They typically provide preclinical and clinical research, clinical trials management, biopharmaceutical and biological assay development, commercialization, and pharmacovigilance.

They give language service providers (LSPs) a steady stream of translation work just from the sheer volume of documentation required in the outsourced projects assigned to them by the so called “Sponsors,” i.e. the large pharma companies that are enlisting the services of CROs. And as the CRO space grows and shifts, LSPs would do well to keep a close eye on the industry.

The CRO space has been growing since it was just a small niche of boutique firms providing a narrow range of outsourcing services to medical and pharmaceutical sciences in the 1990s. Back in those days, academic medical centers were the go-to places for research. In 1994, CRO-run research spending was around $1.6 billion. Ten years later this had ballooned to $7.6 billion. Another ten years later and the revenue of just one of the biggest players in the CRO space exceeds total industry spending 20 years prior: publicly-owned Paraxel, one of the top three CROs in the space, reported that for the full fiscal year ended June 30, 2014, consolidated service revenue was $1.939 billion.

Advertisement

Other big names in the CRO space include Quintiles, PRA, PPD, Icon, inVentiv and INC Research. These companies consistently rank the highest in terms of revenue. And since 2008, the top 10 CROs in the space typically dealt with over half of the work of the entire industry. The rest of the mid-sized and small players usually end up being acquired or going out of business. But even the big players are not immune from a take-over, as evidenced by LabCorp’s recent acquisition of Covance in a $5.7 billion deal.

This continued growth within the CRO space leaves LSPs that have the expertise to deal with the complexities of managing a large CRO account in a strong position to benefit from the industry’s upward trajectory. Furthermore, other developments in technology and digitization such as electronic patient reported outcome and even legislation that regulates clinical trials such as the upcoming EU Regulation No. 536/2014 are seemingly driving even more demand for translation.

This is all good news to LSPs who can successfully maneuver into the good graces of CROs.

TAGS

clinical researchCROlife sciencesmedical translation
SHARE
Gino Diño

By Gino Diño

Content strategy expert and Online Editor for Slator; father, husband, gamer, writer―not necessarily in that order.

Advertisement

SUBSCRIBE TO THE SLATOR WEEKLY

Language Industry Intelligence
In Your Inbox. Every Friday

SUBSCRIBE

SlatorSweepSlatorPro
ResearchRFP CENTER

PUBLISH

PRESS RELEASEDIRECTORY LISTING
JOB ADEVENT LISTING

Bespoke advisory including speaking, briefings and M&A

SLATOR ADVISORY
Advertisement

Featured Reports

See all
Slator 2020 Language Industry M&A and Funding Report

Slator 2020 Language Industry M&A and Funding Report

by Slator

Slator 2021 Data-for-AI Market Report

Slator 2021 Data-for-AI Market Report

by Slator

Slator 2020 Medtech Translation and Localization Report

Slator 2020 Medtech Translation and Localization Report

by Slator

Pro Guide: Sales and Marketing for Language Service Providers

Pro Guide: Sales and Marketing for Language Service Providers

by Slator

Press Releases

See all
iDISC Awarded ISO 27001 Information Security Management Certification

iDISC Awarded ISO 27001 Information Security Management Certification

by iDISC

XTRF Launches a Bi-Monthly Free Networking Event for Localization Professionals

XTRF Launches a Bi-Monthly Free Networking Event for Localization Professionals

by XTRF

150 Million Words Translated: the German EU Council Presidency Translator Sets New Records

150 Million Words Translated: the German EU Council Presidency Translator Sets New Records

by Tilde

Upcoming Events

See All
  1. Memsource MT Post-Editing Pricing Models Webinar

    Pricing Models for MT Post-Editing Workshop

    by Memsource

    · February 3

    Hear a panel of innovative localization professionals share different approaches for MT post-editing pricing.

    More info FREE

Featured Companies

See all
Text United

Text United

Memsource

Memsource

Wordbank

Wordbank

Protranslating

Protranslating

Seprotec

Seprotec

Versacom

Versacom

SDL

SDL

Smartling

Smartling

Lingotek

Lingotek

XTM International

XTM International

Smartcat

Smartcat

Translators without Borders

Translators without Borders

STAR Group

STAR Group

memoQ Translation Technologies

memoQ Translation Technologies

Advertisement

Popular articles

Why Netflix Shut Down Its Translation Portal Hermes

Why Netflix Shut Down Its Translation Portal Hermes

by Esther Bond

The Slator 2020 Language Service Provider Index

The Slator 2020 Language Service Provider Index

by Slator

Top Language Industry Quotes of 2020

Top Language Industry Quotes of 2020

by Monica Jamieson

SlatorPod: The Weekly Language Industry Podcast

connect with us

footer logo

Slator makes business sense of the language services and technology market.

Our Company

  • Support
  • About us
  • Terms & Conditions
  • Privacy Policy

Subscribe to the Slator Weekly

Language Industry Intelligence
In Your Inbox. Every Friday

© 2021 Slator. All rights reserved.

Sign up to the Slator Weekly

Join over 13,000 subscribers and get the latest language industry intelligence every Friday

Your information will never be shared with third parties. No Spam.